It is hypothesized the inverse regulation of MIF/CD74 and CXCR4 expression in B cells in CIS patients with rapid development of CDMS may witness the existence of an immature B cell populations with senescent features, that escaped peripheral tolerance [21]. The gene discussed is MIF; the disease is in situ carcinoma.